ZLAB Q4 2021 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena

ZLABZai Lab Limited

$2B

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$44M+192.6% YoY

Gross Profit

-$150M-338.7% margin

Operating Income

-$219M-496.2% margin

Net Income

-$212M-479.6% margin

EPS (Diluted)

$-22.20

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

-$153M

Free Cash Flow

-$159M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$230M

Stockholders' Equity

$1.4B

Cash & Equivalents

$964M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$15M	+192.6%
Gross Profit	-$150M	-$214M	+30.2%
Operating Income	-$219M	-$95M	-130.1%
Net Income	-$212M	-$77M	-176.7%

Revenue Segments

Zejula

$29M67%

Optune

$12M26%

Qinlock

$3M7%